Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2019 09:00 ET | Source: Fortune Business Insights

U.S Secondary Hyperparathyroidism Treatment (SHPT) Market Size Worth USD 7.06 Billion by 2026; Increasing Launch of Effective Drugs Will Create Growth Opportunities

Pune, Nov. 18, 2019 (GLOBE NEWSWIRE) -- The increasing launch of effective drugs is a key factor driving the U.S. secondary hyperparathyroidism treatment market, says Fortune Business Insights in a...